AI-enabled and comparator digital interventions for adolescent mental health (2020-2025): early detection, human-AI collaboration, and ethical governance-a PRISMA-ScR scoping review.
Noorayisahbe Mohd Yaacob, Mohamed Doheir, Ali Algumaei, Mohammed Nasser Al-Andoli, Jamil Abedalrahim Jamil Alsayaydeh, Abdelrafe Elzamly, Abd Samad Basari
{"title":"AI-enabled and comparator digital interventions for adolescent mental health (2020-2025): early detection, human-AI collaboration, and ethical governance-a PRISMA-ScR scoping review.","authors":"Noorayisahbe Mohd Yaacob, Mohamed Doheir, Ali Algumaei, Mohammed Nasser Al-Andoli, Jamil Abedalrahim Jamil Alsayaydeh, Abdelrafe Elzamly, Abd Samad Basari","doi":"10.3389/frcha.2026.1905782","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Mental health difficulties among adolescents and youth (ages 10-24) are increasing globally, yet early intervention remains impeded by stigma, service shortages, and cultural barriers. AI-enabled technologies including chatbots, automated screening tools, and machine learning-based predictive models have been proposed as scalable approaches to address these gaps, alongside non-AI digital interventions such as therapist-guided internet-delivered cognitive behavioral therapy (iCBT) and smartphone-based CBT applications, which are examined as comparator evidence given their stronger controlled-design evidence base.</p><p><strong>Methods: </strong>This scoping review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) reporting guidelines and Joanna Briggs Institute (JBI) methodology. A systematic database search across six databases (PubMed, Scopus, ProQuest, SpringerLink, Web of Science, and ScienceDirect), supplemented by manual and forward-citation searching, yielded 10,962 records, of which 19 studies met the predefined inclusion criteria. A Human-AI Collaboration Role framework comprising a four-level continuum from fully human-led to fully automated delivery was applied as a predefined coding dimension across all included studies.</p><p><strong>Results: </strong>Most studies focused on depression and anxiety among mid-to-late adolescents in high-income countries (68.4%). Therapist-guided iCBT was the most rigorously studied format using randomized and controlled designs; AI chatbots, predictive models, and large language model (LLM)-based systems demonstrated feasibility or engagement outcomes in a limited number of studies and contexts, though randomized diagnostic chatbot trials specifically remain absent for participants under 18 years; at least one randomized non-diagnostic chatbot trial (a body-image intervention) has been conducted in this age group. Equity-related reporting was inconsistent: socioeconomic status was reported in only 10.5% of studies and cultural adaptation in 42.1%; restriction to English-language publications may further underrepresent non-Western and low- and middle-income-country evidence relevant to these equity findings. Key implementation challenges included inconsistent safeguarding protocols for minors, algorithmic bias, data privacy concerns, and insufficient integration with clinical and educational systems.</p><p><strong>Discussion: </strong>The evidence base remains preliminary and methodologically heterogeneous, insufficient to support conclusions about clinical effectiveness or generalizability to diverse adolescent populations. These findings represent a descriptive map of the current evidence landscape rather than an assessment of effectiveness. Future research should prioritize adequately powered adolescent-focused trials, participatory co-design approaches, culturally informed adaptations, and transparent ethical governance frameworks to ensure responsible development of AI-enabled digital mental health tools for youth. Because the included studies were heterogeneous and no formal risk-of-bias assessment was undertaken, this review does not establish comparative clinical effectiveness, safety, or superiority of AI-enabled interventions.</p><p><strong>Systematic review registration: </strong>https://osf.io/sbpk2, doi: 10.17605/OSF.IO/SBPK2.</p>","PeriodicalId":73074,"journal":{"name":"Frontiers in child and adolescent psychiatry","volume":"5 ","pages":"1905782"},"PeriodicalIF":1.5000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13661949/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in child and adolescent psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frcha.2026.1905782","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Mental health difficulties among adolescents and youth (ages 10-24) are increasing globally, yet early intervention remains impeded by stigma, service shortages, and cultural barriers. AI-enabled technologies including chatbots, automated screening tools, and machine learning-based predictive models have been proposed as scalable approaches to address these gaps, alongside non-AI digital interventions such as therapist-guided internet-delivered cognitive behavioral therapy (iCBT) and smartphone-based CBT applications, which are examined as comparator evidence given their stronger controlled-design evidence base.
Methods: This scoping review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) reporting guidelines and Joanna Briggs Institute (JBI) methodology. A systematic database search across six databases (PubMed, Scopus, ProQuest, SpringerLink, Web of Science, and ScienceDirect), supplemented by manual and forward-citation searching, yielded 10,962 records, of which 19 studies met the predefined inclusion criteria. A Human-AI Collaboration Role framework comprising a four-level continuum from fully human-led to fully automated delivery was applied as a predefined coding dimension across all included studies.
Results: Most studies focused on depression and anxiety among mid-to-late adolescents in high-income countries (68.4%). Therapist-guided iCBT was the most rigorously studied format using randomized and controlled designs; AI chatbots, predictive models, and large language model (LLM)-based systems demonstrated feasibility or engagement outcomes in a limited number of studies and contexts, though randomized diagnostic chatbot trials specifically remain absent for participants under 18 years; at least one randomized non-diagnostic chatbot trial (a body-image intervention) has been conducted in this age group. Equity-related reporting was inconsistent: socioeconomic status was reported in only 10.5% of studies and cultural adaptation in 42.1%; restriction to English-language publications may further underrepresent non-Western and low- and middle-income-country evidence relevant to these equity findings. Key implementation challenges included inconsistent safeguarding protocols for minors, algorithmic bias, data privacy concerns, and insufficient integration with clinical and educational systems.
Discussion: The evidence base remains preliminary and methodologically heterogeneous, insufficient to support conclusions about clinical effectiveness or generalizability to diverse adolescent populations. These findings represent a descriptive map of the current evidence landscape rather than an assessment of effectiveness. Future research should prioritize adequately powered adolescent-focused trials, participatory co-design approaches, culturally informed adaptations, and transparent ethical governance frameworks to ensure responsible development of AI-enabled digital mental health tools for youth. Because the included studies were heterogeneous and no formal risk-of-bias assessment was undertaken, this review does not establish comparative clinical effectiveness, safety, or superiority of AI-enabled interventions.